Details of the Drug

General Information of Drug (ID: DMB5XRY)

Drug Name

SAR446309

Indication

Disease Entry	ICD 11	Status	REF
Aggressive cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of Sanofi